Top

Reactions Weekly

Published in:

01-07-2023 | Ciclosporine | Case report

Immunosuppressants

Reactivation of latent Epstein-Barr virus and Cytomegalovirus infections and lack of efficacy: 10 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Speth P, et al. Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein-Barr Virus and Cytomegalovirus Infection. Journal of Investigative Dermatology 142 : 549-558, No. 3, Mar 2022. Available from: URL: http://doi.org/10.1016/j.jid.2021.07.171

Title: Immunosuppressants
Reactivation of latent Epstein-Barr virus and Cytomegalovirus infections and lack of efficacy: 10 case reports
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Ciclosporine
Inverse Psoriasis
Pyoderma Gangrenosum
Epstein-Barr Virus
Infliximab
Azathioprine
Azathioprine
Lichen Sclerosus Et Atrophicus
Rituximab
Rituximab
Common Pemphigus
Methotrexate
Methotrexate
Prednisolone
Ixekizumab
Mycophenolate Mofetil
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43218-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Immunosuppressants

Reactivation of latent Epstein-Barr virus and Cytomegalovirus infections and lack of efficacy: 10 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Glecaprevir/pibrentasvir

Piperacillin/tazobactam

Asparaginase

Vedolizumab

Multiple drugs

Gemcitabine/oxaliplatin